Access to anti-retroviral drugs, male in Rwanda

Rwanda: Access to anti-retroviral drugs, male was 95.0% in 2024. ◆ Volatile

Latest (2024)
95.0%
Change on year
up 1.1%
World rank
4th
of 141 countries
All-time high
95.0%
in 2024
All-time low
0.0%
in 2000
Years of data
25
2000–2024

Access to anti-retroviral drugs, male in Rwanda, 2000–2024

0204060801002000201220242000: 0 %2001: 0 %2002: 0 %2003: 0 %2004: 3 %2005: 8 %2006: 15 %2007: 19 %2008: 27 %2009: 32 %2010: 37 %2011: 42 %2012: 47 %2013: 51 %2014: 56 %2015: 63 %2016: 71 %2017: 74 %2018: 77 %2019: 82 %2020: 85 %2021: 87 %2022: 89 %2023: 94 %2024: 95 %

Source: UNAIDS estimates. Measured in %.

Analysis

In 2024, access to anti-retroviral drugs, male in Rwanda stood at 95.0%. That is the highest value across all 25 years on record.

The figure is up 1.1% on the previous year and up 69.6% over ten years.

Over the whole period, access to anti-retroviral drugs, male in Rwanda peaked at 95.0% in 2024 and was at its lowest, 0.0%, in 2000.

That places Rwanda 4th out of 141 countries with data for 2024, putting it in the top 10%.

The series is highly variable year to year, so single readings are best treated with caution.

Access to anti-retroviral drugs, male in Rwanda, year by year

Annual values for Access to anti-retroviral drugs, male (%) in Rwanda, 2000 to 2024.
Year % Change
2000 0.0%
2001 0.0%
2002 0.0%
2003 0.0%
2004 3.0%
2005 8.0% +166.7%
2006 15.0% +87.5%
2007 19.0% +26.7%
2008 27.0% +42.1%
2009 32.0% +18.5%
2010 37.0% +15.6%
2011 42.0% +13.5%
2012 47.0% +11.9%
2013 51.0% +8.5%
2014 56.0% +9.8%
2015 63.0% +12.5%
2016 71.0% +12.7%
2017 74.0% +4.2%
2018 77.0% +4.1%
2019 82.0% +6.5%
2020 85.0% +3.7%
2021 87.0% +2.4%
2022 89.0% +2.3%
2023 94.0% +5.6%
2024 95.0% +1.1%

Averages by decade

DecadeAverage LowestHighest Years
2000s 10.4% 0.0% 32.0% 10
2010s 60.0% 37.0% 82.0% 10
2020s 90.0% 85.0% 95.0% 5

Countries ranked near Rwanda

  1. 1 Comoros 98.0% compare
  2. 2 Mauritania 97.0% compare
  3. 3 Cambodia 96.0% compare
  4. 4 Sweden 95.0% compare
  5. 4 Zambia 95.0% compare
  6. 7 Denmark 93.0% compare
  7. 7 Ethiopia 93.0% compare
  8. 7 Saudi Arabia 93.0% compare
  9. 7 United Kingdom of Great Britain and Northern Ireland 93.0% compare

See the full ranking of 160 places →

More gender data for Rwanda

All data for Rwanda →

Frequently asked questions

What is access to anti-retroviral drugs, male in Rwanda?
Access to anti-retroviral drugs, male in Rwanda was 95.0% in 2024, according to UNAIDS estimates.
What is the highest access to anti-retroviral drugs, male recorded in Rwanda?
The highest recorded value was 95.0% in 2024.
What is the lowest access to anti-retroviral drugs, male recorded in Rwanda?
The lowest recorded value was 0.0% in 2000.
How does Rwanda rank for access to anti-retroviral drugs, male?
Rwanda ranks 4th out of 141 countries with data for 2024.
Is access to anti-retroviral drugs, male rising or falling in Rwanda?
Over the last ten years it is up 69.6%. The long-run trend across the full record is volatile.
Where does this Rwanda data come from?
The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, male (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).

Share, cite or embed this page

Cite this page

Access to anti-retroviral drugs, male in Rwanda. Statizoid, drawing on UNAIDS estimates. Retrieved 08 September 2026, from https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-male-percent/rwanda/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-male-percent/rwanda/">Access to anti-retroviral drugs, male in Rwanda</a> — Statizoid

About this data

Indicator
Access to anti-retroviral drugs, male (%)
Unit
%
Source
UNAIDS estimates
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
160 places, 3,923 data points, 2000–2024
Last refreshed

The percentage of adult males living with HIV who are receiving antiretroviral therapy.